TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29618071

Group type: EXPERIMENTAL
Intervention: Neuronavigation (image guidance)
Number of subjects: 203

Group type: COMPARATOR
Intervention: No image guidance (control group)
Number of subjects: 203
Study: 28822635

Group type: EXPERIMENTAL
Intervention: Biocomposite interference screws
Number of subjects: 51
Study: 23549516

Group type: EXPERIMENTAL
Intervention: Metipranolol (10 mg twice per day)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 23405020

Group type: EXPERIMENTAL
Intervention: Preoperative physical therapy (respiratory and global exercises) for 2-3 weeks before surgery
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Preoperative physical therapy
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (await operation without engaging in practicing)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Intervention group (preoperative physical therapy)
Number of subjects: 32
Study: 21989099

Group type: EXPERIMENTAL
Intervention: Weight monitoring and recording (measured, recorded, and announced twice a week for 3 months)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (weight measured and recorded once at the beginning and once at the end of the study)
Number of subjects: 79
Study: 18829219

Group type: EXPERIMENTAL
Intervention: Balneotherapy associated with patient education (spa treatment course in La Léchère) consisting of four balneology sessions per day, six days a week for three weeks, and three educational workshops.
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group received spa treatment starting at day 365 (after the treatment group).
Number of subjects: 59
Study: 16213470

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 15541857

Group type: EXPERIMENTAL
Intervention: Cleavage stage embryo transfer (2-3 days culture)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Blastocyst stage embryo transfer (5-6 days culture)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Good quality embryo transfer (day 2-3)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Good quality embryo transfer (day 5-6)
Number of subjects: 144
Study: 11328684

Group type: EXPERIMENTAL
Intervention: 10-minute exposure to a previously recorded 10 kHz-sferics impulse with a pulse repetition frequency of 1 to 3 Hz.
Number of subjects: 80

Group type: COMPARATOR
Intervention: No treatment (control group).
Number of subjects: 80
Study: 9218070

Group type: EXPERIMENTAL
Intervention: Regular coffee (300 mL)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Decaffeinated coffee (300 mL)
Number of subjects: 17
Study: 8525856

Group type: EXPERIMENTAL
Intervention: Moclobemide (300-600 mg/day)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Sertraline (50-200 mg/day)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Overall group (Moclobemide and Sertraline)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 55
Study: 2492322

Group type: EXPERIMENTAL
Intervention: Continuous nitroglycerin patches (10 mg/day)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intermittent nitroglycerin patches (10 mg/day) for 18 h/day with 6 h off
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intermittent nitroglycerin patches (10 mg/day) for 14 h/day with 10 h off
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Intermittent treatment (10 h off)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 36
Study: 4623522

Group type: EXPERIMENTAL
Intervention: Phenytoin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (without phenytoin)
Number of subjects: 9
Study: 30924702

Group type: EXPERIMENTAL
Intervention: SPN-812 200 mg/day
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: SPN-812 300 mg/day
Number of subjects: 222

Group type: EXPERIMENTAL
Intervention: SPN-812 400 mg/day
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 30734832

Group type: EXPERIMENTAL
Intervention: Darmocare Pre® (inulin and fructooligosaccharides) for 13 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (maltodextrin) for 13 weeks
Number of subjects: 50
Study: 28887006

Group type: EXPERIMENTAL
Intervention: Travoprost (0.004%)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Timolol (0.25% for patients aged 2 months to <3 years and 0.5% for patients ≥3 years old)
Number of subjects: 157

Group type: COMPARATOR
Intervention: Travoprost vs Timolol
Number of subjects: 157
Study: 25227967

Group type: EXPERIMENTAL
Intervention: Initial high-dose prednisolone combination therapy using COBRA regimen (methotrexate and sulfasalazine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: COBRA-light variation of COBRA combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-dose methotrexate and infliximab combination therapy
Number of subjects: 0
Study: 23138523

Group type: EXPERIMENTAL
Intervention: Unconstrained hands
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Constrained hands
Number of subjects: 0
Study: 21777013

Group type: EXPERIMENTAL
Intervention: Olmesartan medoxomil 20 mg/day, uptitrated to 40 mg/day or combined with HCTZ 40/12.5 mg/day or 40/25 mg/day
Number of subjects: 192
Study: 20084816

Group type: EXPERIMENTAL
Intervention: Classroom training plus reinforcement
Number of subjects: 120

Group type: COMPARATOR
Intervention: Classroom training only
Number of subjects: 120

Group type: COMPARATOR
Intervention: No training
Number of subjects: 120
Study: 18046863

Group type: EXPERIMENTAL
Intervention: Oral theophylline
Number of subjects: 18
Study: 15718612

Group type: EXPERIMENTAL
Intervention: PCLX Laryngograph Processor and Nosality digital modules
Number of subjects: 0
Study: 11207321

Group type: EXPERIMENTAL
Intervention: IC14 (1 mg/kg over 1 h)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: IC14
Number of subjects: 16
Study: 9281302

Group type: EXPERIMENTAL
Intervention: 15 mg lansoprazole daily
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 300 mg ranitidine daily
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 7506323

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 40 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 60 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS) 20 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Beraprost sodium (BPS)
Number of subjects: 12
Study: 3129273

Group type: EXPERIMENTAL
Intervention: Combined insulin and glibenclamide (Euglucon N)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Insulin alone (placebo)
Number of subjects: 68
Study: 29795403

Group type: EXPERIMENTAL
Intervention: 2-mg dose of nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27988164

Group type: EXPERIMENTAL
Intervention: Single-dose interscalene block and general anesthesia (SISB/GA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 62
Study: 26699871

Group type: EXPERIMENTAL
Intervention: Minor homozygote genotype of rs7968585 SNP
Number of subjects: 8461

Group type: COMPARATOR
Intervention: Major homozygote genotype of rs7968585 SNP
Number of subjects: 8461
Study: 23886454

Group type: EXPERIMENTAL
Intervention: Sevoflurane: SS
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane-propofol: SP
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol-propofol: PP
Number of subjects: 60
Study: 21041606

Group type: EXPERIMENTAL
Intervention: Fluoxetine hydrochloride treatment
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Combination of fluoxetine and cognitive behavioral therapy
Number of subjects: 196

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 196
Study: 18320371

Group type: EXPERIMENTAL
Intervention: Forearm support band
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Strengthening exercises
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 29
Study: 16359772

Group type: EXPERIMENTAL
Intervention: Triptorelin (3.75 mg i.m.)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Leuprolin (3.75 mg i.m.)
Number of subjects: 60
Study: 14521759

Group type: EXPERIMENTAL
Intervention: IL-2 + 3PaZ(TH)L(2)VE(AK) + 4PaL(2)V
Number of subjects: 209

Group type: COMPARATOR
Intervention: 3PaZ(TH)L(2)VE(AK)/4PaL(2)V
Number of subjects: 209
Study: 11139917

Group type: EXPERIMENTAL
Intervention: Right atrial septal pacing
Number of subjects: 36

Group type: COMPARATOR
Intervention: Conventional right atrial pacing
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Atrial multisite pacing
Number of subjects: 36
Study: 8799270

Group type: EXPERIMENTAL
Intervention: Gas chromatography/combustion/carbon isotope ratio mass spectrometry (GC/C/IRMS) analysis of urinary steroids
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Gas chromatography/combustion/carbon isotope ratio mass spectrometry (GC/C/IRMS)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Measurement of carbon isotope ratios of urinary androgens
Number of subjects: 8
Study: 1361356

Group type: EXPERIMENTAL
Intervention: Rocuronium (0.6 mg kg‐1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Vecuronium (0.08 mg kg‐1)
Number of subjects: 0
Study: 6487444

Group type: EXPERIMENTAL
Intervention: Nalbuphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 0
Study: 30741425

Group type: EXPERIMENTAL
Intervention: Early endovenous ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deferred endovenous ablation
Number of subjects: 0
Study: 29705832

Group type: EXPERIMENTAL
Intervention: 120 W PVP
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 180 W PVP
Number of subjects: 84
Study: 26586300

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF) applied to one side of the face post-surgery.
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo PEMF device applied to the control side of the face post-surgery.
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Comfort evaluation using a numerical rating scale for PEMF devices.
Number of subjects: 11
Study: 24923345

Group type: EXPERIMENTAL
Intervention: Exercise group (n = 18) - running 15 minutes at medium intensity (65-75% HRmax)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Psychosocial stress group (n = 19)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 55
Study: 23008295

Group type: EXPERIMENTAL
Intervention: 0.625 mg conjugated equine estrogen plus 2.5 mg medroxyprogesterone acetate
Number of subjects: 16508

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16508
Study: 19952863

Group type: EXPERIMENTAL
Intervention: HPV‐6/11/16/18 vaccine
Number of subjects: 21480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21480
Study: 17636242

Group type: EXPERIMENTAL
Intervention: Vaginal suppositories containing 2.5 mg bromocriptine mesthylate with pluronics and bioadhesive agents, once daily for 1 month
Number of subjects: 171

Group type: COMPARATOR
Intervention: Commercial 2.5 mg bromocriptine mesthylate tablets inserted vaginally, once daily for 1 month
Number of subjects: 171
Study: 15642811

Group type: EXPERIMENTAL
Intervention: 12-hour self-management program
Number of subjects: 214

Group type: COMPARATOR
Intervention: Tape-recorded health lectures
Number of subjects: 214

Group type: COMPARATOR
Intervention: Waiting list
Number of subjects: 214
Study: 12146001

Group type: EXPERIMENTAL
Intervention: Exemestane 10 mg/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Exemestane 25 mg/day
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Total group (10 mg + 25 mg)
Number of subjects: 67
Study: 10413640

Group type: EXPERIMENTAL
Intervention: Efegatran at 1.2 mg. kg(‐1). h(‐1)
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Efegatran (various doses)
Number of subjects: 432

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Efegatran
Number of subjects: 432

Group type: EXPERIMENTAL
Intervention: Efegatran at levels of at least 0.63 mg. kg(‐1). h(‐1)
Number of subjects: 432
Study: 7768238

Group type: EXPERIMENTAL
Intervention: 6.9% CHO solution
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 5.5% CHO solution
Number of subjects: 7

Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 7
Study: 2272094

Group type: EXPERIMENTAL
Intervention: Manual therapy
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cold packs
Number of subjects: 19
Study: 7306430

Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg three times daily and 400 mg at night for 6 days
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 31888709

Group type: EXPERIMENTAL
Intervention: Individually tailored activity and exercise programme delivered using motivational theory, with up to 50 supervised sessions over one year.
Number of subjects: 368

Group type: COMPARATOR
Intervention: Brief falls prevention assessment (control).
Number of subjects: 368
Study: 28009637

Group type: EXPERIMENTAL
Intervention: Infiniti Plus needle guide
Number of subjects: 0

Group type: COMPARATOR
Intervention: No Infiniti Plus needle guide
Number of subjects: 0
Study: 26404039

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural intervention combined with breathing relaxation exercise for four weeks
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 89
Study: 24144703

Group type: EXPERIMENTAL
Intervention: ECMO with cooling (34°C for the first 48 to 72 hours)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard ECMO (37°C)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: ECMO with cooling
Number of subjects: 111

Group type: COMPARATOR
Intervention: Standard ECMO
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Secondary outcomes (death, neonatal morbidity, neurodevelopmental and behavioral outcomes)
Number of subjects: 111
Study: 21970738

Group type: EXPERIMENTAL
Intervention: Various management approaches suggested for poor responders in assisted conception, specific interventions not detailed.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Review of current evidence on management of poor responders, specific interventions not detailed.
Number of subjects: 0
Study: 19203712

Group type: EXPERIMENTAL
Intervention: Zinc supplementation (0, 15 or 30 mg Zn per day for 6 months)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group (0 mg Zn per day for 6 months)
Number of subjects: 3
Study: 17900060

Group type: EXPERIMENTAL
Intervention: Twinrix (GSK)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Havrix (GSK) and Engerix-B (GSK)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Vaqta (Sanofi Pasteur) and HB VAX PRO (Sanofi-Pasteur)
Number of subjects: 3
Study: 15131531

Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hormone therapy
Number of subjects: 0
Study: 11855146

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CsA) in combination with corticosteroid (prednisone + danazol)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Conventional regimen alone (prednisone + danazol)
Number of subjects: 44
Study: 9771080

Group type: EXPERIMENTAL
Intervention: Latanoprost (0.005% xalathane solution)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of latanoprost with pilocarpine + timolol
Number of subjects: 0
Study: 7930743

Group type: EXPERIMENTAL
Intervention: Artesunate (10 mg/kg over 3 days) plus mefloquine (25 mg/kg)
Number of subjects: 652

Group type: COMPARATOR
Intervention: High-dose mefloquine alone
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Mefloquine on day 2 of treatment
Number of subjects: 652
Study: 3280484

Group type: EXPERIMENTAL
Intervention: Random-zero sphygmomanometer
Number of subjects: 66

Group type: COMPARATOR
Intervention: Standard mercury sphygmomanometer
Number of subjects: 66
Study: 29908345

Group type: EXPERIMENTAL
Intervention: Repetitions to failure (RFG, n=17)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Repetitions not to failure (NFG, n=20)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Repetitions not to failure with total volume equalized to that in the RFG (ENFG, n=15)
Number of subjects: 52

Group type: COMPARATOR
Intervention: All CT groups (RFG, NFG, ENFG)
Number of subjects: 52
Study: 27745629

Group type: EXPERIMENTAL
Intervention: Hair follicle-containing punch grafts
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonhairy punch grafts (Control)
Number of subjects: 12
Study: 24525910

Group type: COMPARATOR
Intervention: TCZ + PBO
Number of subjects: 63

Group type: COMPARATOR
Intervention: TCZ + MTX
Number of subjects: 63
Study: 22428914

Group type: COMPARATOR
Intervention: Reference formulation (Glucobay® 100 mg tablet)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Test formulation (generic acarbose 100 mg tablet)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 19573960

Group type: EXPERIMENTAL
Intervention: T-Diet Plus (n-3 polyunsaturated fatty acid-enriched diet)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Jevity (enteral diet intended for elderly)
Number of subjects: 65
Study: 18942249

Group type: EXPERIMENTAL
Intervention: Single Lumen Tube (SLT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Double Lumen Tube (DLT)
Number of subjects: 30
Study: 17937364

Group type: EXPERIMENTAL
Intervention: 200 mg of caffeine
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 12722964

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS) 200 microg daily
Number of subjects: 245
Study: 11097979

Group type: EXPERIMENTAL
Intervention: Amantadine
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 9113472

Group type: EXPERIMENTAL
Intervention: Snack bar containing uncooked cornstarch (bar 1)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control bar (bar 2)
Number of subjects: 79
Study: 8469785

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) 400 mg three times daily for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 25
Study: 4035629

Group type: EXPERIMENTAL
Intervention: Dilute hydrochloric acid (0.001 N)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: More concentrated hydrochloric acid (0.01 N)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acid drink (0.001 N)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Reflux associated with acid drink response
Number of subjects: 18
Study: 30204981

Group type: EXPERIMENTAL
Intervention: Tonsillectomy and pharyngoplasty
Number of subjects: 603

Group type: COMPARATOR
Intervention: Tonsillectomy alone
Number of subjects: 603
Study: 26850676

Group type: EXPERIMENTAL
Intervention: Test drug (orally inhaled salbutamol)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Reference drug (orally inhaled salbutamol)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 24
Study: 24902481

Group type: EXPERIMENTAL
Intervention: Nurse-led intervention (SAMS)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 211
Study: 22382087

Group type: EXPERIMENTAL
Intervention: Nonstandard RapidArc (RA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Standard RapidArc (RA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: HDR‐BRT
Number of subjects: 27

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 27

Group type: COMPARATOR
Intervention: Integral doses
Number of subjects: 27
Study: 21102969

Group type: COMPARATOR
Intervention: OM-ER 15 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: OM-ER 30 mg
Number of subjects: 35
Study: 18319295

Group type: EXPERIMENTAL
Intervention: International Program on Chemical Safety Poison Severity Score (IPCS PSS)
Number of subjects: 1365

Group type: EXPERIMENTAL
Intervention: Glasgow Coma Score (GCS)
Number of subjects: 1365

Group type: EXPERIMENTAL
Intervention: Glasgow Coma Score (GCS) for dimethoate poisoning
Number of subjects: 1365

Group type: EXPERIMENTAL
Intervention: Glasgow Coma Score (GCS) for fenthion poisoning
Number of subjects: 1365
Study: 15952100

Group type: EXPERIMENTAL
Intervention: 3 MIU rIFN‐beta‐1a (group A)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: 1 MIU rIFN‐beta‐1a (group B)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 91
Study: 12600910

Group type: COMPARATOR
Intervention: Fluoroscopic guidance with standard sampling (3 to 6 samples per patient)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Pericardioscopy guidance with standard sampling (4 to 6 samples per patient)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Pericardioscopy guidance with extensive sampling (18 to 20 samples per patient)
Number of subjects: 49
Study: 10224679

Group type: EXPERIMENTAL
Intervention: Low energy laser radiation treatment in addition to routine antibiotic therapy
Number of subjects: 68

Group type: COMPARATOR
Intervention: Routine antibiotic therapy
Number of subjects: 68
Study: 8903538

Group type: EXPERIMENTAL
Intervention: Cardiac amyloidosis patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study: 2004544

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 125 mg twice daily
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Cefuroxime axetil 250 mg twice daily
Number of subjects: 672

Group type: EXPERIMENTAL
Intervention: Adverse events reported
Number of subjects: 672
Study: 6572041

Group type: EXPERIMENTAL
Intervention: Artificial forward relocation of the center of mass of the head
Number of subjects: 0
Study: 30713722

Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 mg twice daily
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 394

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study: 29203893

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) intervention (1200-1500 Kcal/day meal plans and physical activity)
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) intervention
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44